Opcet Ophthalmic Solution 0.24%
Opcet Ophthalmic Solution 0.24% Uses, Dosage, Side Effects, Food Interaction and all others data.
| Trade Name | Opcet Ophthalmic Solution 0.24% |
| Generic | Cetirizine Hydrochloride (Ophthalmic) |
| Weight | 0.24% |
| Type | Ophthalmic Solution |
| Therapeutic Class | Ophthalmic Anti-allergic preparations |
| Manufacturer | Ibn Sina Pharmaceuticals Ltd. |
| Available Country | Bangladesh |
| Last Updated: | October 19, 2023 at 6:27 am |
Uses
Cetirizine 0.24% ophthalmic solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis.Dosage
Opcet Ophthalmic Solution 0.24% dosage
Adults and children (age 2 years and above): The recommended dosage is to instill one drop in the affected eye(s) twice daily (approximately 8 hours apart).Side Effects
The most common adverse reactions are ocular hyperemia, instillation site pain and visual acuity reduction.Precaution
Care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle to prevent contaminating the tip and solution. Keep the bottle closed when not in use. Patients should be advised not to wear a contact lens if their eye is red. Remove contact lenses prior to instillation of the drug. Lenses may be reinserted after 10 minutes following the drug administration.Pregnancy & Breastfeeding use
Pregnancy: There is no adequate or well-controlled study with Cetirizine 0.24% ophthalmic solution in pregnant women. It should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.Lactation: It is not known whether the systemic absorption resulting from topical ocular administration of Cetirizine could produce detectable quantities in human breast milk. There is no adequate information regarding the effects of Cetirizine on breastfed infants, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for this drug and any potential adverse effects on the breastfed child from Cetirizine.Special Warning
Pediatric use: The safety and effectiveness have been established in pediatric patients two years of age and older.Geriatric use: No overall differences in safety or effectiveness have been observed between elderly and younger patients.Storage Condition
Do not store above 30⁰C. Do not freeze. Protect from light. Do not use more than 4 weeks after opening. Keep out of the reach of children.Innovators Monograph
You find simplified version here Opcet Ophthalmic Solution 0.24%
